| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/19/1995 | CN1105264A Antihypertensive body-building bath vinegar containing Chinese medicine |
| 07/19/1995 | CA2140498A1 Method for preventing or reducing risk of onset of cardiovascular events employing an hmg coa reductase |
| 07/18/1995 | US5434185 Method for inhibiting angiogenesis with aurintricarboxylic acid, its analogues or salts |
| 07/18/1995 | US5434184 Chemical compounds |
| 07/18/1995 | US5434173 Heteroaryl substituted phenylethenyl compounds having retinoid-like biological activity |
| 07/18/1995 | US5434168 4-[(2-benzothiazolyl)methylamino]-alpha-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol |
| 07/18/1995 | US5434167 Imidazolines N-substituted by a biphenylmethyl group, their medical use and the pharmaceutical compositions therefor |
| 07/18/1995 | US5434162 Quinolinyl/isoquinolinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 07/18/1995 | US5434160 Autoimmune diseases; prevention of excess cell proliferation or enzyme release |
| 07/18/1995 | US5434153 Cardiovascular disorders |
| 07/18/1995 | US5434149 Phosphodiesterase inhibitors |
| 07/18/1995 | US5434141 Medicament for the treatment of hyperlipidaemia and/or atherosclerosis |
| 07/18/1995 | US5434137 Method for selective opening of abnormal brain tissue capillaries |
| 07/18/1995 | US5434134 Use of human IGF-1 to treat cardiac disorders |
| 07/18/1995 | CA1336326C Microbeads of diltiazem, a process for their manufacture and a sustained-release pharmaceutical composition containing them |
| 07/15/1995 | CA2139720A1 Sulfuric acid esters of sugar alcohols |
| 07/13/1995 | WO1995018803A1 Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
| 07/13/1995 | WO1995018625A1 The composition containing snapping turtle and tortoise, the preparation and the use thereof |
| 07/13/1995 | WO1995018621A1 Methods of inhibiting angiogenesis and tumor growth, and treating ophthalmologic conditions with angiostatic and therapeutic steroids |
| 07/13/1995 | WO1995018620A1 Treatment using arachidonic acid metabolite and particulate formulations |
| 07/13/1995 | WO1995018619A1 Bicyclic fibrinogen antagonists |
| 07/13/1995 | WO1995018616A2 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/nmda receptor |
| 07/13/1995 | WO1995018610A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| 07/13/1995 | WO1995018609A1 Human leukocyte 12-lipoxygenase, mediation of its pathway, and consequences thereof |
| 07/13/1995 | CA2180360A1 Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
| 07/13/1995 | CA2180123A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| 07/13/1995 | CA2180122A1 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the usethereof as antagonists for the glycine/nmda receptor |
| 07/13/1995 | CA2179986A1 Treatment using arachidonic acid metabolite and particulate formulations |
| 07/12/1995 | EP0662471A2 Naphthalene derivatives with affinity to the receptors of melatonine, process for their preparation and pharmaceutical compositions containing them |
| 07/12/1995 | EP0662137A1 Gene transcription and ionizing radiation: methods and compositions |
| 07/12/1995 | EP0662087A1 Retinal pigmented epithelium derived neurotrophic factor |
| 07/12/1995 | EP0661992A1 Pharmaceutical formulations of interleukin-1 inhibitors |
| 07/12/1995 | EP0661991A1 Methods for treating renin-related disorders with amylin antagonists |
| 07/12/1995 | EP0661971A1 Methods and compositions for treating hypertension, angina, and other disorders using optically pure s(-) felodipine |
| 07/12/1995 | EP0661970A1 Methods and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine |
| 07/12/1995 | CN1104888A Pharmaceutical composition for preventing or treating arteriosclerosis |
| 07/11/1995 | US5432282 Process for preparing 1,4-dihydro-2-amino-3-carboxy-5-cyano-pyridine derivatives |
| 07/11/1995 | US5432189 Bis-aryl amide and urea antagonists of platelet activating factor |
| 07/11/1995 | US5432185 Haemorheological use of N-alkylated 1,4-dihydropyridine-dicarboxylic acid esters, and some new compounds |
| 07/11/1995 | US5432181 Substituted heteroaryl analogs of 4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
| 07/11/1995 | US5432169 Cyclopentanperhydrophenanthren-17β-(3-furyl)-3-derivatives and pharmaceutical compositions comprising same for the treatment of cardiovascular disorders |
| 07/11/1995 | US5432159 N-(α-substituted-pyridinyl)carbonyl dipeptide antihypertensive agents |
| 07/06/1995 | WO1995018144A1 Steroidal glycosides |
| 07/06/1995 | WO1995018143A1 Hypocholesterolemic agents |
| 07/06/1995 | WO1995018142A1 Wf15604 substances |
| 07/06/1995 | WO1995018131A1 New ginkgolide derivatives and a process for preparing them |
| 07/06/1995 | WO1995018128A1 Pyrazolopyridine adenosine antagonists |
| 07/06/1995 | WO1995018118A1 Heterocyclic compounds for the treatment of cns and cardiovascular disorders |
| 07/06/1995 | WO1995018105A1 1,3-dihydroindol-2-one derivatives substituted in position 3 by a nitrogen group as vasopressin and/or ocytocine agonists and/or antagonists |
| 07/06/1995 | WO1995018101A1 Prostaglandin derivative, salt thereof, and use thereof |
| 07/06/1995 | WO1995018099A1 Aminocarboxylic acid amides, process for preparing the same and their use as anti-arrhythmic agents |
| 07/06/1995 | WO1995017907A1 Methods and compositions for inhibiting thrombogenesis |
| 07/06/1995 | WO1995017906A1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 07/06/1995 | WO1995017905A1 Ileal bile acid transporter compositions and methods |
| 07/06/1995 | WO1995017904A2 Botulinum toxins for treating various disorders and associated pain |
| 07/06/1995 | WO1995017902A1 Use of a strain of the fungus fusarium as a substance producer and a preparation based on it with adaptogenic and immunomodulating properties |
| 07/06/1995 | WO1995017876A2 2,4-disulphophenyl butylnitrone, its salts, and their use as pharmaceutical spintraps |
| 07/06/1995 | CA2682117A1 The use of the neurotoxic component of a botulinum toxin for the treatment of a facial disease, disorder or condition |
| 07/06/1995 | CA2180359A1 Ileal bile acid transporter compositions and methods |
| 07/06/1995 | CA2180253A1 Pyrazolopyridine adenosine antagonists |
| 07/06/1995 | CA2180149A1 Steroidal glycosides |
| 07/06/1995 | CA2180148A1 Hypocholesterolemic agents |
| 07/06/1995 | CA2180140A1 Methods and compositions for inhibiting thrombogenesis |
| 07/06/1995 | CA2179981A1 Prostaglandin derivative, salt thereof, and use thereof |
| 07/06/1995 | CA2179810A1 Aminocarboxylic acid amides, process for preparing the same and their use as anti-arrhythmic agents |
| 07/06/1995 | CA2177736A1 New ginkgolide derivatives and a process for preparing them |
| 07/06/1995 | CA2176722A1 Heterocyclic compounds for the treatment of cns and cardiovascular disorders |
| 07/05/1995 | EP0661292A1 Orally active renin inhibitors |
| 07/05/1995 | EP0661272A1 Novel imidazolinoxyl derivatives |
| 07/05/1995 | EP0661269A1 Substituted heterocyclic carboxylic acid amides, their preparation and their use as medicaments |
| 07/05/1995 | EP0661264A1 Substituted benzenesulfonylureas and -thioureas as antiarrhythmics |
| 07/05/1995 | EP0661260A1 New bi-aromatic compounds derived from amides pharmaceutical compositions and cosmetic compositions containing them and their use |
| 07/05/1995 | EP0661051A2 Medicament for the treatment of perfusion changes |
| 07/05/1995 | EP0660832A1 Serotonin receptor agents |
| 07/05/1995 | EP0660719A1 Method and composition for ameliorating tissue damage due to ischemia and reperfusion |
| 07/05/1995 | EP0660716A1 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| 07/05/1995 | EP0660713A1 Use of angiotensin ii antagonists in the treatment of left ventricular hypertrophy |
| 07/05/1995 | EP0660707A1 Method of preventing nmda receptor-mediated neuronal damage |
| 07/05/1995 | CN1104634A Compounds with a sulphamoyl and amidino group, process for preparing them and pharmaceutical compositions containing them |
| 07/05/1995 | CN1029230C Method for preparing of hydroxamic acid and N-hydroxyurea derivatives |
| 07/04/1995 | US5430116 Polymers and oligomers of bile acid derivatives, process for their preparation and their use as pharmaceuticals |
| 07/04/1995 | US5430048 Spirocyclic benzopyran imidazolines |
| 07/04/1995 | US5430031 Serotoninergic ergoline derivatives |
| 07/04/1995 | US5430027 2-chloro-N6 -substituted adenosines, their pharmaceutical compositions, and activity in treating ischemias |
| 07/04/1995 | US5429928 Measuring ouabain level using an antibody having binding specificity to ouabain |
| 07/04/1995 | CA1336195C Aryloxyphenylpropylamines and their preparation and use |
| 07/04/1995 | CA1336192C Pharmaceutical benzoheterocyclylcarboxamide derivatives |
| 07/04/1995 | CA1336191C Sulfhydryl containing tricyclic lactams and their pharmacological methods of use |
| 07/01/1995 | CA2138929A1 Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals |
| 06/29/1995 | WO1995017507A1 ANTISENSE NUCLEIC ACIDS FOR THE PREVENTION AND TREATMENT OF DISORDERS IN WHICH EXPRESSION OF c-erbB PLAYS A ROLE |
| 06/29/1995 | WO1995017410A1 Heterocyclic compounds |
| 06/29/1995 | WO1995017402A1 New pyridazino[4',5':3,4]pyrrolo-[2,1-a]isoquinolines and their use for preparing pharmaceutical compositions |
| 06/29/1995 | WO1995017401A1 Dyhydrobenzofuranyl-biphenyl carboxamides having 5ht1d antagonistic activity |
| 06/29/1995 | WO1995017398A1 Indole, indoline and quinoline derivatives with 5ht1d (anti-depressive) activity |
| 06/29/1995 | WO1995017396A1 Polymorphs of losartan and the process for the preparation of form ii of losartan |
| 06/29/1995 | WO1995017393A1 4,5-diaryloxazole derivatives |
| 06/29/1995 | WO1995017389A1 Anellated dihydropyridines and their use in the production of pharmaceutical preparations |
| 06/29/1995 | WO1995017388A1 Anellated dihydropyridines and their use in the production of pharmaceutical preparations |
| 06/29/1995 | WO1995017182A1 Protein kinase c inhibitors |
| 06/29/1995 | WO1995017092A1 MACROPHAGE INFLAMMATORY PROTEINS-3, -4 AND -1¿η? |